Richard W Pascoe is Chief Executive Officer of KEMPHARM, INC. Currently has a direct ownership of 29,973 shares of KMPH, which is worth approximately $148,066. The most recent transaction as insider was on Mar 09, 2023, when has been sold 10,000 shares (Common Stock) at a price of $4.2 per share, resulting in proceeds of $42,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
0% 12M change
Total Value Held $148,066

Richard W Pascoe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2023
BUY
Open market or private purchase
$42,000 $4.2 p/Share
10,000 Added 25.02%
29,973 Common Stock
Jan 13 2023
BUY
Open market or private purchase
$51,680 $5.44 p/Share
9,500 Added 32.23%
19,973 Common Stock
May 18 2022
BUY
Open market or private purchase
$24,600 $4.92 p/Share
5,000 Added 37.64%
8,285 Common Stock
Nov 30 2021
BUY
Open market or private purchase
$11,820 $7.88 p/Share
1,500 Added 31.35%
3,285 Common Stock

Also insider at

HSTO
Histogen Inc. Healthcare
SEEL
SEELOS THERAPEUTICS, INC. Healthcare
RWP

Richard W Pascoe

Chief Executive Officer
San Diego, CA

Track Institutional and Insider Activities on KMPH

Follow KEMPHARM, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KMPH shares.

Notify only if

Insider Trading

Get notified when an Kempharm, Inc insider buys or sells KMPH shares.

Notify only if

News

Receive news related to KEMPHARM, INC

Track Activities on KMPH